UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$235M |
| 2 |
Microsoft
MSFT
|
+$176M |
| 3 |
Cognizant
CTSH
|
+$150M |
| 4 |
Chubb
CB
|
+$107M |
| 5 |
Under Armour
UAA
|
+$100M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$221M |
| 2 |
Workday
WDAY
|
+$133M |
| 3 |
Pfizer
PFE
|
+$122M |
| 4 |
Apple
AAPL
|
+$122M |
| 5 |
Nike
NKE
|
+$116M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.48% |
| 2 | Technology | 14.7% |
| 3 | Financials | 13.4% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Communication Services | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
8x8 Inc
EGHT
$315M
| $11.1M | 0.01% |
1,102,308
-45,511
| -4% | -$499K |
|
777
BlackBerry
BB
$5.25B
| $11.1M | 0.01% |
1,360,151
-26,711
| -2% | -$200K |
|
778
Casey's General Stores
CASY
$30.7B
| $11M | 0.01% |
97,127
+57,848
| +147% | +$6.48M |
|
779
Burlington
BURL
$23.2B
| $11M | 0.01% |
194,939
+132,305
| +211% | +$6.91M |
|
|
MACK
780
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $11M | 0.01% |
166,344
+5,588
| +3% | +$292K |
|
781
Teck Resources
TECK
$32.1B
| $10.9M | 0.01% |
1,432,058
+46,973
| +3% | +$254K |
|
782
Toll Brothers
TOL
$14.2B
| $10.9M | 0.01% |
369,389
-11,750
| -3% | -$328K |
|
783
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
| $10.9M | 0.01% |
41,372
+37,936
| +1,104% | +$9.24M |
|
|
CMCM
784
Cheetah Mobile
CMCM
$97.2M
| $10.9M | 0.01% |
133,000
+3,160
| +2% | +$244K |
|
785
Idacorp
IDA
$8.21B
| $10.8M | 0.01% |
144,283
-4,189
| -3% | -$296K |
|
|
DVAX
786
DELISTED
Dynavax Technologies
DVAX
| $10.8M | 0.01% |
558,964
+542,627
| +3,321% | +$11M |
|
787
Webster Financial
WBS
$12.8B
| $10.7M | 0.01% |
297,571
-16,800
| -5% | -$575K |
|
|
LHO
788
DELISTED
LaSalle Hotel Properties
LHO
| $10.7M | 0.01% |
421,691
-115,276
| -21% | -$2.73M |
|
|
BEAV
789
DELISTED
B/E Aerospace Inc
BEAV
| $10.6M | 0.01% |
230,823
-9,660
| -4% | -$413K |
|
790
Diamondback Energy
FANG
$52.9B
| $10.6M | 0.01% |
137,530
-6,855
| -5% | -$484K |
|
791
Trip.com Group
TCOM
$28.9B
| $10.5M | 0.01% |
236,752
-24,200
| -9% | -$1.01M |
|
792
Wendy's
WEN
$1.47B
| $10.4M | 0.01% |
954,492
+742,432
| +350% | +$7.36M |
|
|
TTM
793
DELISTED
Tata Motors Limited
TTM
| $10.3M | 0.01% |
355,900
-3,100
| -0.9% | -$78.3K |
|
794
AMC Entertainment Holdings
AMC
$2.35B
| $10.3M | 0.01% |
36,934
-1,654
| -4% | -$396K |
|
795
Ligand Pharmaceuticals
LGND
$6.28B
| $10.3M | 0.01% |
153,455
-11,308
| -7% | -$687K |
|
|
AMSG
796
DELISTED
Amsurg Corp
AMSG
| $10.1M | 0.01% |
135,787
+100,821
| +288% | +$7.1M |
|
797
Carlisle Companies
CSL
$15.4B
| $10.1M | 0.01% |
101,804
+47,053
| +86% | +$4.15M |
|
798
Omega Healthcare
OHI
$14.7B
| $10.1M | 0.01% |
286,038
-85,310
| -23% | -$2.79M |
|
|
WBMD
799
DELISTED
WebMD Health Corp.
WBMD
| $10.1M | 0.01% |
160,698
+136,845
| +574% | +$7.33M |
|
800
COPT Defense Properties
CDP
$4.23B
| $10.1M | 0.01% |
383,457
+15,868
| +4% | +$368K |
|
Similar funds
UBS AM's Q1 2016 Portfolio in Review
As of Q1 2016, UBS AM held 2,740 positions worth $86.2B, down 1.7% from $87.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS AM's Q1 2016 filing shows 51 new, 583 increased, 1,774 reduced and 113 closed positions. Its largest new stake was NXP Semiconductors: 1,291,575 shares worth $105M. The largest sale was Thermo Fisher Scientific, an estimated $221M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q1 2016 buy was NXP Semiconductors: 1,291,575 shares worth $105M.
- UBS AM added most to Alibaba in Q1 2016, an estimated $235M increase.
- UBS AM's biggest Q1 2016 reduction was Thermo Fisher Scientific, cutting an estimated $221M.
- UBS AM fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $97.5M.
- UBS AM's ten largest holdings make up 15% of its $86.2B portfolio in Q1 2016.
- UBS AM opened 51 new positions and closed 113 in Q1 2016.
- UBS AM's portfolio value fell 1.7% quarter-over-quarter to $86.2B.
Based on UBS AM's 13F filing for Q1 2016, filed 12 May 2016.